NASDAQ: NVCR
Novocure Ltd Stock

$22.93-1.25 (-5.17%)
Updated Feb 6, 2025
NVCR Price
$22.93
Fair Value Price
$0.96
Market Cap
$2.48B
52 Week Low
$11.70
52 Week High
$34.13
P/E
-16.5x
P/B
6.88x
P/S
2.93x
PEG
N/A
Dividend Yield
N/A
Revenue
$577.74M
Earnings
-$149.78M
Gross Margin
76.4%
Operating Margin
-27.51%
Profit Margin
-25.9%
Debt to Equity
2.39
Operating Cash Flow
-$37M
Beta
1.18
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NVCR Overview

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NVCR's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
B
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
NVCR
Ranked
#37 of 128

Top Ranked Stocks in Industry

View Top Medical Device Stocks

Be the first to know about important NVCR news, forecast changes, insider trades & much more!

NVCR News

Overview

Due Diligence Score

–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NVCR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVCR ($22.93) is overvalued by 2,278.28% relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NVCR ($22.93) is not significantly undervalued (2,278.28%) relative to our estimate of its Fair Value price of $0.96 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NVCR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NVCR due diligence checks available for Premium users.

Valuation

NVCR fair value

Fair Value of NVCR stock based on Discounted Cash Flow (DCF)

Price
$22.93
Fair Value
$0.96
Overvalued by
2,278.28%
NVCR ($22.93) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NVCR ($22.93) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NVCR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NVCR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-16.5x
Industry
41.05x
Market
31.69x

NVCR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
6.88x
Industry
4.35x
NVCR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVCR's financial health

Profit margin

Revenue
$155.1M
Net Income
-$30.6M
Profit Margin
-19.7%
NVCR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NVCR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.2B
Liabilities
$861.2M
Debt to equity
2.39
NVCR's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVCR's short-term assets ($1.10B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVCR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NVCR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$10.4M
Investing
$10.2M
Financing
$100.0k
NVCR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NVCR vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NVCRC$2.48B-5.17%-16.50x6.88x
TMDXC$2.47B-1.43%74.24x11.75x
TNDMC$2.41B+0.14%-19.04x10.15x
LIVNA$2.60B-1.54%109.02x1.99x
UFPTC$2.15B-1.79%39.54x6.53x

Novocure Stock FAQ

What is Novocure's quote symbol?

(NASDAQ: NVCR) Novocure trades on the NASDAQ under the ticker symbol NVCR. Novocure stock quotes can also be displayed as NASDAQ: NVCR.

If you're new to stock investing, here's how to buy Novocure stock.

What is the 52 week high and low for Novocure (NASDAQ: NVCR)?

(NASDAQ: NVCR) Novocure's 52-week high was $34.13, and its 52-week low was $11.70. It is currently -32.82% from its 52-week high and 95.98% from its 52-week low.

How much is Novocure stock worth today?

(NASDAQ: NVCR) Novocure currently has 108,201,434 outstanding shares. With Novocure stock trading at $22.93 per share, the total value of Novocure stock (market capitalization) is $2.48B.

Novocure stock was originally listed at a price of $18.28 in Oct 2, 2015. If you had invested in Novocure stock at $18.28, your return over the last 9 years would have been 25.44%, for an annualized return of 2.55% (not including any dividends or dividend reinvestments).

How much is Novocure's stock price per share?

(NASDAQ: NVCR) Novocure stock price per share is $22.93 today (as of Feb 6, 2025).

What is Novocure's Market Cap?

(NASDAQ: NVCR) Novocure's market cap is $2.48B, as of Feb 7, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novocure's market cap is calculated by multiplying NVCR's current stock price of $22.93 by NVCR's total outstanding shares of 108,201,434.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.